Encompass Health Corporation $EHC Position Boosted by Bahl & Gaynor Inc.

Bahl & Gaynor Inc. increased its holdings in Encompass Health Corporation (NYSE:EHC) by 14.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 288,226 shares of the company’s stock after purchasing an additional 37,161 shares during the quarter. Bahl & Gaynor Inc. owned 0.29% of Encompass Health worth $35,345,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Congress Asset Management Co. bought a new position in shares of Encompass Health in the second quarter valued at $92,691,000. Nuveen LLC acquired a new position in shares of Encompass Health in the 1st quarter worth $50,665,000. T. Rowe Price Investment Management Inc. raised its position in shares of Encompass Health by 25.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock worth $210,756,000 after purchasing an additional 424,691 shares during the period. Strs Ohio purchased a new stake in shares of Encompass Health during the first quarter valued at $34,364,000. Finally, American Century Companies Inc. boosted its position in shares of Encompass Health by 78.6% in the 1st quarter. American Century Companies Inc. now owns 723,169 shares of the company’s stock valued at $73,243,000 after purchasing an additional 318,251 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Up 1.5%

EHC opened at $114.44 on Friday. The company has a market capitalization of $11.51 billion, a PE ratio of 21.63, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $127.99. The business has a 50-day moving average of $121.34 and a 200-day moving average of $119.54.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. The firm had revenue of $136.30 million for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s payout ratio is presently 14.37%.

Analyst Ratings Changes

Several analysts have issued reports on the company. KeyCorp boosted their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Bank of America boosted their price target on shares of Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday. UBS Group increased their price target on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd. Finally, Truist Financial boosted their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research report on Thursday, August 14th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $142.86.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the firm’s stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. This trade represents a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is owned by insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.